Medications

Reckitt pays US $1.4bn to settle opioid treatment spat

British consumer health giant Reckitt Benckiser announced Thursday it will pay up to $1.4 billion (1.2 billion euros) to settle a dispute with US authorities over the sale and marketing of an opioid addiction treatment.

Health

FDA targets vaping 'influencers' for online promotions

U.S. regulators moved to discipline vaping companies for inappropriately promoting their flavored nicotine formulas through so-called influencers on Facebook, Twitter and other social media sites.

Genetics

Who does (and doesn't) want a DNA ancestry test?

At-home DNA testing kits may be the latest fad, but according to new research by Stanford sociologists, not everyone is keen to find out whether they are related to the British royal family or a Neanderthal.

page 1 from 17